MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.35 0.0 (0.0%)	0.02 (0.86%)	0.06 (2.62%)	0.04 (1.73%)	0.0 (0.0%)	-0.01 (-0.75%)	0.9 (67.67%)	1.02 (76.69%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: PreMarket

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -26.1111
Diluted P/E:: -26.1111
RSI(14) 1m:: 71.98
VWAP:: 2.34
RVol:: 13.8758

Events

Period	Kind	Movement	Occurred At
10m	Price increase 10m	2.89 +0.15 (+5.47%)	Oct 16 05:44
1m	Price increase 1m	2.89 +0.12 (+4.33%)	Oct 16 05:44
1m	Price increase 1m	2.73 +0.06 (+2.25%)	Oct 16 05:41
1m	Price decrease 1m	2.66 -0.08 (-2.92%)	Oct 16 05:40
1m	Price decrease 1m	2.73 -0.04 (-1.44%)	Oct 16 05:39